Insider Transactions in Q3 2021 at Fulcrum Therapeutics, Inc. (FULC)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 22
2021
|
Mark J Levin Director |
SELL
Other acquisition or disposition
|
Indirect |
1,000,000
-16.77%
|
-
|
|
Sep 22
2021
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,000,000
-16.77%
|
-
|
|
Aug 11
2021
|
Bryan Stuart Director |
SELL
Open market or private sale
|
Direct |
28,000
-100.0%
|
$644,000
$23.75 P/Share
|
|
Aug 11
2021
|
Bryan Stuart Director |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+50.0%
|
$196,000
$7.84 P/Share
|
|
Aug 10
2021
|
Bryan Stuart Director |
SELL
Open market or private sale
|
Direct |
32,000
-100.0%
|
$544,000
$17.5 P/Share
|
|
Aug 10
2021
|
Bryan Stuart Director |
BUY
Exercise of conversion of derivative security
|
Direct |
32,000
+50.0%
|
$224,000
$7.84 P/Share
|
|
Aug 10
2021
|
Christopher Moxham Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
31,071
-100.0%
|
$559,278
$18.0 P/Share
|
|
Aug 10
2021
|
Christopher Moxham Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
51,785
+50.0%
|
$362,495
$7.84 P/Share
|
|
Aug 10
2021
|
Christopher Moxham Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,714
-100.0%
|
$352,138
$17.0 P/Share
|